Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20210704002
TCTR20210704002
Not Yet Recruiting
Phase 4

Efficacy of intralesional botulinum toxin injection in nail psoriasis patients: A Double-blinded Randomized Controlled Trial

Chulabhorn International College of Medicine, Thammasat University0 sites18 target enrollmentJuly 4, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsail psoriasis patients with at least 4 fingernails involvement.nail psoriasis, psoriatic nail, botulinum toxin injection

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
ail psoriasis patients with at least 4 fingernails involvement.
Sponsor
Chulabhorn International College of Medicine, Thammasat University
Enrollment
18
Status
Not Yet Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 4, 2021
End Date
February 28, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Chulabhorn International College of Medicine, Thammasat University

Eligibility Criteria

Inclusion Criteria

  • •1\. Patient aged at least 20 years old.
  • •2\. Psoriatic nail patients who have at least 4 psoriatic nails.
  • •3\. Each enrolled nail has target NAPSI score at least 3 points.

Exclusion Criteria

  • •1\. Patients refusel to participate the study
  • •2\. Patients are using topical nail therapies within 2 weeks.
  • •3\. Patients are receiving oral therapies within 4 weeks.
  • •4\. Patients have active nail infection.
  • •5\. Patient with sensitivity or allergy to constituents of the botulinum toxin product, vitamin D , corticosteroid, cows milk protein or lidocaine
  • •6\. Patient with neuromuscular disorder or peripheral motor neuropathic disease (e.g. amyotrophic lateral sclerosis, myasthenia gravis, Lambert Eaton syndrome, myopathies)
  • •7\. Pregnancy or breastfeeding
  • •8\. Unrealistic expectation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
Evaluation of botulinum toxin injection efficacy in the treatment of head essential tremorTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2015-000162-59-FRCHU Clermont-Ferrand120
Active, Not Recruiting
Phase 1
Botox injection in 1st toe to treat spasticityThe application of Botox is described in the technical sheet for spasticity and has already been applied to the foot. This is how we speak of a phase IV clinical trial, with a low level of intervention.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2020-005653-24-ESClínica Integral del pie-Ana Sans120
Completed
N/A
Safety and efficacy of botulinum toxin injection therapy on patients with esophageal motility disordersEsophageal motility disorders except for achalasia
JPRN-UMIN000021190Gunma University Hospital5
Not Yet Recruiting
N/A
De effectiviteit van botuline toxine A als injectie in de bekkenbodemspier bij patiënten met chronische bekkenpijn: een dubbel-geblindeerde, gerandomiseerde studie.chronic pelvic pain with pelvic floor hypertonicity
NL-OMON20966Radboudumc, Nijmegen92
Active, Not Recruiting
Phase 1
The efficacy of botulin toxin A injection in the pelvic floor muscles in the treatment of chronic pelvic pain.Patients with >6 months or recurrent episodes of abdomino-perineo-pelvic pain, hypersensitivity or discomfort often associated with elimination changes, and sexual dysfunction in the absence of organic etiology (definition of the International Continence Society (ICS)) with (primary of secondary) pelvic floor muscle hypertonicity refractory to first line pelvic floor physiotherapy, willing to participate in this trial.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2017-001296-23-NLRadboudumc92